Methods related to opioid therapeutics
View Patent ↗The present invention provides methods for modulating opioid receptor mediated analgesic effect, e.g., promoting or enhancing analgesia in subjects in need of pain relief. Also provided in the invention are methods for ameliorating or suppressing withdrawal symptoms in subjects with chronic opioid use. These methods of the invention entail administering to the subjects in need of treatment a therapeutically effective amount of a GPR139 antagonist compound. The invention further provides methods for identifying novel compounds that can be useful for modulating opioid receptor mediated analgesic effect.
1. A method for suppressing or ameliorating withdrawal symptoms in subjects with chronic use of an opioid drug, comprising administering to the subject a pharmaceutical composition comprising an effective amount of a compound that down-regulates expression or cellular activity of GPR139 or an ortholog thereof, wherein the compound is a small organic molecule, thereby suppressing or ameliorating withdrawal symptoms in the subject.
2. The method of claim 1 , wherein the subject is administered the pharmaceutical composition after discontinuing use of the opioid drug.
3. The method of claim 2 , wherein the opioid drug is oxycodone, hydrocodone, morphine, codeine or fentanyl.
4. The method of claim 1 , wherein the subject is at risk of developing withdrawal symptoms or is a risk of relapse.
5. The method of claim 1 , wherein the subject is a human.
6. The method of claim 1 , wherein the compound down-regulates GPCR signaling activity of GPR139 or an ortholog thereof.
7. The method of claim 1 , wherein the compound is a small organic compound selected from the group consisting of:
8. A method for diminishing reinforcing effects of, or preventing or treating addiction to, opioid drugs in a subject, comprising administering to the subject a pharmaceutical composition comprising an effective amount of a compound that up-regulates expression or cellular activity of GPR139 or an ortholog thereof, wherein the compound is a small organic molecule, thereby diminishing reinforcing effects of, or preventing or treating addiction to, opioid drugs in the subject.
9. The method of claim 8 , wherein the GRP139 agonist compound administered to the subject is selected from following table:
or
or a Glycine benzamide.
10. A method for identifying an agent that modulates the μ-opioid receptor (MOR) signaling, comprising (a) screening test compounds to identify one or more modulating compounds that modulate expression or cellular activity of GPR139 or an ortholog thereof, and (b) testing the modulating compounds for ability to modulate an MOR signaling related activity; thereby identifying a MOR modulator.